Valion Bio, Inc. VBIO
Set alert
0.55 USD -0.07 -10.83%
At close · Oct 30
0.53 -0.02 -3.56%
After hours · Oct 30, 7:32 PM ET
0.5237 Day range 0.6026
0.55 52-week range 66.50
- YTD
- -98.48%
- 1 year
- -99.12%
- Open
- 0.60
- Prev close
- 0.6168
- Mkt cap
- 1.15M
- Vol
- 219.94K
- Avg vol
- 1.98M
- EPS
- -177.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5237
- High
- 0.6026
2Y chart
Events in this range
- Aug 31, 2026Split: 1 for 25
Signals (68)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 14, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| RSI: Oversold | Sep 8, 2026 | 1 month ago |
| RSI: Oversold | Aug 27, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| RSI: Oversold | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 21, 2026 | 3 months ago |
| RSI: Oversold | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 11, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 10, 2026 | 4 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bullish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | May 1, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 15, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| SMA: Bullish | Mar 24, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 18, 2026 | 8 months ago |
| RSI: Oversold | Feb 11, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 8 months ago |
| RSI: Oversold | Feb 3, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 21, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 19, 2025 | 10 months ago |
| SMA: Bearish | Dec 12, 2025 | 10 months ago |
| SMA: Bullish | Dec 11, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| RSI: Oversold | Nov 19, 2025 | 11 months ago |
| RSI: Oversold | Nov 13, 2025 | 11 months ago |
| RSI: Oversold | Nov 6, 2025 | 11 months ago |
| RSI: Oversold | Nov 3, 2025 | 12 months ago |
| RSI: Oversold | Oct 30, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 22, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 10, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 19, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 14, 2025 | 1 year ago |
| RSI: Oversold | Aug 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 29, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 17, 2025 | 1 year ago |
| SMA: Bearish | Jul 11, 2025 | 1 year ago |
| SMA: Bullish | Jul 9, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 20, 2025 | 1 year ago |
| SMA: Bearish | May 23, 2025 | 1 year ago |
| SMA: Bullish | May 14, 2025 | 1 year ago |
| SMA: Bearish | May 13, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| MACD: Sell Signal | May 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 29, 2025 | 1 year ago |
| SMA: Bullish | Apr 22, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 2, 2025 | 1 year ago |
| SMA: Bearish | Mar 5, 2025 | 1 year ago |
| SMA: Bullish | Mar 4, 2025 | 1 year ago |
| SMA: Bearish | Mar 3, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 26, 2025 | 1 year ago |
| SMA: Bullish | Feb 12, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 12, 2025 | 1 year ago |
| RSI: Overbought | Feb 12, 2025 | 1 year ago |
| SMA: Bearish | Jan 23, 2025 | 1 year ago |
| SMA: Bullish | Jan 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 14, 2025 | 1 year ago |
Financials — quick view
VBIO Revenue — quarterly 0
VBIO Net income — quarterly -7.10M
VBIO EPS — quarterly -54.00
News
- 12 Health Care Stocks Moving In Friday's After-Market Session
- Valion Bio Announces That The Armed Forces Radiobiology Research Institute Will Evaluate The Therapeutic Efficacy Of Entolimod
- Valion Bio Announces Final Data From Entolimod Study For Hematopoietic And Gastrointestinal Forms Of Acute Radiation Syndrome; AFRRI Study Found No Evidence Of Treatment-Related Toxicity After One Dose Of Entolimod, Supporting Advancement Toward A Fully Funded Therapeutic Study
- Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Valion Bio Confirms Receipt Of Proposed Acquisition Offers For Its Velocity Bioworks; Terms Undisclosed
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Valion Bio's New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Valion Bio's Velocity Biowork Subsidiary Completes Initial Feasibility Evaluation Of LarmorBio's BioScan-NMR Platform
Your note
Sign in to keep a note on VBIO — it syncs with the Stock Master app.